Long-term melatonin use among patients with insomnia is associated with negative cardiac effects, new research suggests.

Expert researchers and clinicians from the Leon H. Charney Division of Cardiology at NYU Langone will present practice-changing studies, translational research, and clinical insights at the 2025 ...

Seer’s presence at HUPO 2025 represents one of the most comprehensive demonstrations of its technology to date, with more than a dozen scientific presentations, including two invited talks in the ...

New research into a popular sleeping aid has some scientists worried about long-term usage. An analysis of adults with ...

Cardiovascular disease (CVD), a composite of coronary heart disease (CHD), cerebrovascular disease, and heart failure, ...

The prevalence of overweight and obesity has reached pandemic proportions, affecting more than 1 billion people worldwide; it represents a major driver of cardiovascular morbidity, mortality, and ...

Decor is not just for aesthetics, according to an international team of cell biologists. Surprising groups saw the toughest effects.

New trial shows stem cells prevent heart failure after heart attack, offering hope for cardiac recovery. Keep reading.

Empagliflozin therapy was associated with improved kidney outcomes regardless of diabetes, HF, cause of kidney disease, or severity of kidney disease.

A multi-institution research team led by Georgetown University Medical Center has developed and validated a model estimating ...

In a breakthrough for diagnostics, scientists have created an easy and effective test that identifies a heart failure ...

Heart failure is a leading cause of death and disability. Unfortunately, this affects millions of individuals and their loved ...